The US Department of Defense, along with the Department of Health and Human Services, has awarded a $79.9m contract to Premix to build a plastic compound manufacturing plant in North Carolina.

The facility will mainly manufacture plastic materials for diagnostic testing.

It will be constructed in Gaston County, and is expected to become operational by September 2025.

Premix Group managing director Hanna Ristola said: “Our hard work in building resilient supply chains, high product quality and consistency pays off as the U.S. government awarded Premix the deal to build a local manufacturing site.”

The Finnish-based company is a manufacturer of electrically conductive plastics.

The new facility will manufacture plastic compounds mainly suitable for pipette tips to cater to the increasing demand and quality requirements for diagnostic testing.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

This increased production capacity will lead to material for pipette tips, allowing over 200 million Covid-19 PCR tests monthly.

Premix president and CEO Jari-Matti Mehto said: “The new capacity will improve Premix’s global supply capability and mitigate risks in global supply chains.

“With the new U.S. factory, we will improve our ability to serve our customers in the important U.S. market.”

Once completely operational, the facilities will employ about 30-35 people in Gaston County, North Carolina, as well as support further jobs with service providers and subcontractors during the construction and operational phases.

Mehto added: “We are extremely excited about this opportunity to help secure a supply of critical diagnostic materials in the United States.

“Our solutions meet strict standards for quality and cost-efficiency and provide valuable benefits to our new and existing customers.

—————————————————————————————————————–

Image: The facility will be constructed in Gaston County, and is expected to become operational by September 2025. Credit: marcinjozwiak from Pixabay.